Lipid Metabolism — MCQs

Lipid Metabolism Indian Medical PG Practice Questions and MCQs

Question 431: How many carbon atoms are added in fatty acid synthesis?

A. 2 in the first cycle and 4 in the second cycle
B. 4 in the first cycle and 2 in the second cycle (Correct Answer)
C. 2 in the first cycle and 2 in the second cycle
D. 4 in the first cycle and 4 in the second cycle

Explanation: ### Explanation The synthesis of fatty acids (Lipogenesis) occurs in the cytoplasm via the **Fatty Acid Synthase (FAS) multienzyme complex**. Understanding the carbon count requires looking at the "priming" step versus the "elongation" steps. **1. Why Option B is Correct:** * **First Cycle:** The process begins with one molecule of **Acetyl-CoA (2C)** and one molecule of **Malonyl-CoA (3C)**. During the condensation reaction, one carbon is lost as $CO_2$. Therefore, $2 + 3 - 1 = 4$ carbons. The first product formed is Butyryl-ACP (a 4-carbon chain). * **Subsequent Cycles:** In every following cycle, only one **Malonyl-CoA (3C)** is added to the existing chain. Again, one carbon is lost as $CO_2$, resulting in a net addition of **2 carbons** per cycle. * Thus, the sequence is 4 carbons in the first cycle and 2 carbons in all subsequent cycles until Palmitate (16C) is formed. **2. Why Other Options are Wrong:** * **Option A & D:** These are incorrect because the first cycle must account for the initial Acetyl-CoA primer plus the first Malonyl-CoA unit, totaling 4 carbons. * **Option C:** This is a common trap. While it is true that 2 carbons are *net* added from Malonyl-CoA in each step, the first cycle results in a 4-carbon molecule because it starts from a 2-carbon Acetyl-CoA base. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Rate-limiting enzyme:** Acetyl-CoA Carboxylase (requires **Biotin**). * **Reductant:** **NADPH** is the essential electron donor (primarily from the HMP Shunt). * **End Product:** The FAS complex specifically releases **Palmitate (16:0)**. Further elongation occurs in the endoplasmic reticulum. * **Citrate Shuttle:** Acetyl-CoA moves from mitochondria to cytosol in the form of Citrate ("Citrate is for Synthesis").

Question 432: Beta-oxidation of an odd-carbon fatty acid chain produces which of the following?

A. Succinyl CoA
B. Propionyl CoA (Correct Answer)
C. Acetyl CoA
D. Malonyl CoA

Explanation: **Explanation:** The beta-oxidation of fatty acids involves the sequential removal of two-carbon units in the form of **Acetyl CoA**. For even-chain fatty acids, this process continues until the entire chain is converted into Acetyl CoA. However, **odd-chain fatty acids** undergo the same spiral until the final cleavage step, which leaves a **three-carbon fragment** known as **Propionyl CoA** along with Acetyl CoA. **Why Propionyl CoA is correct:** In the final round of beta-oxidation for an odd-numbered chain (e.g., C17), the 5-carbon intermediate is cleaved into one Acetyl CoA (2C) and one Propionyl CoA (3C). Propionyl CoA is the unique end-product of odd-chain fatty acid metabolism. **Analysis of Incorrect Options:** * **A. Succinyl CoA:** While Propionyl CoA eventually enters the TCA cycle as Succinyl CoA, it requires a three-step enzymatic pathway (involving Biotin and Vitamin B12). Succinyl CoA is a *metabolite* of Propionyl CoA, not the direct product of beta-oxidation. * **C. Acetyl CoA:** While Acetyl CoA is produced during every turn of beta-oxidation, it is common to both even and odd chains. The question asks what is specifically produced due to the "odd-carbon" nature, which is Propionyl CoA. * **D. Malonyl CoA:** This is an intermediate of fatty acid **synthesis** (lipogenesis), not breakdown (beta-oxidation). It acts as a potent inhibitor of Carnitine Palmitoyltransferase-I (CPT-I). **High-Yield Clinical Pearls for NEET-PG:** * **The Propionyl CoA Pathway:** Propionyl CoA → Methylmalonyl CoA (via *Propionyl CoA Carboxylase* + **Biotin**) → Succinyl CoA (via *Methylmalonyl CoA Mutase* + **Vitamin B12**). * **Clinical Correlation:** Deficiency of Vitamin B12 leads to the accumulation of Methylmalonic acid (Methylmalonic Aciduria) and secondary neurological damage. * **Gluconeogenesis:** Unlike even-chain fatty acids, odd-chain fatty acids are **glucogenic** because Propionyl CoA converts to Succinyl CoA, which can enter the gluconeogenic pathway.

Question 433: In Gaucher's disease, there is accumulation of which substance inside the cells?

A. Galactosidase
B. Sphingomyelin
C. Glucosidase
D. Cerebroside (Correct Answer)

Explanation: **Explanation:** **Gaucher’s disease** is the most common lysosomal storage disorder. It is caused by a deficiency of the enzyme **Glucocerebrosidase** (also known as $\beta$-glucosidase). Under normal physiological conditions, this enzyme cleaves glucose from glucocerebroside. In its absence, **Glucocerebroside (a type of Glucosylceramide/Cerebroside)** accumulates within the lysosomes of macrophages. **Analysis of Options:** * **D. Cerebroside (Correct):** Specifically, **Glucocerebroside** is the substrate that builds up in the reticuloendothelial system (spleen, liver, and bone marrow). * **A. Galactosidase:** This is an enzyme, not a storage substance. Deficiency of $\alpha$-galactosidase A causes Fabry disease, while deficiency of $\beta$-galactosidase causes Krabbe disease. * **B. Sphingomyelin:** This substance accumulates in **Niemann-Pick disease** due to a deficiency of the enzyme sphingomyelinase. * **C. Glucosidase:** This refers to the enzyme itself (Glucocerebrosidase). A deficiency of the enzyme leads to the disease, but the enzyme does not accumulate; its substrate does. **High-Yield Clinical Pearls for NEET-PG:** * **Gaucher Cells:** Pathognomonic macrophages found in bone marrow aspirates described as having a **"wrinkled paper"** or **"crumpled silk"** appearance. * **Clinical Triad:** Hepatosplenomegaly, bone involvement (Erlenmeyer flask deformity of the femur, bone crises), and pancytopenia. * **Biochemical Marker:** Elevated levels of serum **Chitotriosidase** are often used to monitor disease activity and treatment response. * **Treatment:** Enzyme Replacement Therapy (ERT) with recombinant imiglucerase is the gold standard.

Question 434: Sphingolipids are chiefly accumulated in which of the following tissues?

A. Cardiac muscle
B. Adipose tissue
C. Skeletal muscle
D. Central nervous system (CNS) (Correct Answer)

Explanation: **Explanation:** **1. Why the Correct Answer is Right:** Sphingolipids are a class of lipids containing a backbone of sphingosine (an amino alcohol) rather than glycerol. They are essential structural components of **biological membranes**, particularly the **myelin sheath** that insulates axons. The **Central Nervous System (CNS)** and peripheral nerves have the highest concentration of sphingolipids (such as sphingomyelin, cerebrosides, and gangliosides) to facilitate rapid nerve impulse conduction. Consequently, the brain and neural tissues are the primary sites of sphingolipid accumulation and turnover. **2. Why Incorrect Options are Wrong:** * **Adipose tissue:** This is the primary storage site for **Triacylglycerols (TAGs)**, which serve as the body's energy reservoir. It contains very little sphingolipid compared to neural tissue. * **Skeletal and Cardiac muscle:** These tissues primarily utilize fatty acids and glucose for energy. While they contain phospholipids in their cell membranes, they do not accumulate sphingolipids in significant quantities. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Sphingolipidoses:** These are lysosomal storage disorders caused by deficiencies in enzymes that degrade sphingolipids. Because these lipids are most abundant in the CNS, these diseases typically present with **neurodegeneration**, developmental delay, and cognitive decline. * **Key Examples:** * **Niemann-Pick Disease:** Deficiency of *Sphingomyelinase*; leads to accumulation of sphingomyelin (look for "Foam cells" and Cherry-red spot). * **Tay-Sachs Disease:** Deficiency of *Hexosaminidase A*; leads to accumulation of $GM_2$ gangliosides (look for Cherry-red spot, no hepatosplenomegaly). * **Gaucher’s Disease:** Most common sphingolipidosis; deficiency of *Glucocerebrosidase* (look for "Crumpled tissue paper" appearance of macrophages). * **Precursor:** All sphingolipids are derived from **Ceramide** (Sphingosine + Fatty acid).

Question 435: All of the following are phospholipids, EXCEPT?

A. Cardiolipin
B. Cerebroside (Correct Answer)
C. Sphingomyelin
D. Surfactant lipid

Explanation: **Explanation:** The classification of lipids is based on their chemical composition. **Phospholipids** must contain a phosphate group, whereas **Glycolipids** contain a carbohydrate moiety. **Why Cerebroside is the Correct Answer:** Cerebroside is a **Glycolipid** (specifically a neutral glycosphingolipid). It consists of a ceramide backbone (sphingosine + fatty acid) attached to a single sugar unit (glucose or galactose). Crucially, it **lacks a phosphate group**, which excludes it from the phospholipid category. **Analysis of Incorrect Options:** * **Cardiolipin (Diphosphatidylglycerol):** A complex glycerophospholipid found exclusively in the inner mitochondrial membrane. It is essential for the optimal function of the electron transport chain. * **Sphingomyelin:** This is the only phospholipid that contains **sphingosine** instead of glycerol as its backbone. It is a major component of the myelin sheath. * **Surfactant lipid (Dipalmitoylphosphatidylcholine/DPPC):** Also known as Lecithin, this is a glycerophospholipid. It reduces surface tension in the alveoli, preventing lung collapse. **High-Yield Clinical Pearls for NEET-PG:** * **Cardiolipin** is the antigen used in the **VDRL test** for Syphilis; it is also the target of antibodies in Antiphospholipid Antibody Syndrome (APS). * **Sphingomyelinase deficiency** leads to **Niemann-Pick Disease**, characterized by hepatosplenomegaly and "foam cells." * **Lecithin-Sphingomyelin (L/S) ratio** in amniotic fluid is used to assess fetal lung maturity; a ratio >2 indicates low risk of Respiratory Distress Syndrome (RDS). * **Cerebrosides** accumulate in **Gaucher disease** (Glucocerebroside) and **Krabbe disease** (Galactocerebroside).

Question 436: In an elderly patient, what is the best indicator for calculating the probability of developing cardiovascular disease?

A. LDL/HDL ratio (Correct Answer)
B. Triglycerides
C. Total cholesterol
D. Serum LDL

Explanation: **Explanation:** The risk of cardiovascular disease (CVD) is not determined solely by the absolute level of one lipid fraction, but by the balance between pro-atherogenic and anti-atherogenic lipoproteins. **Why LDL/HDL ratio is the correct answer:** The **LDL/HDL ratio** (also known as the Castelli Index I) is a superior predictor of cardiovascular risk because it reflects the clinical "tug-of-war" between cholesterol deposition and clearance. * **LDL (Low-Density Lipoprotein):** Transports cholesterol from the liver to peripheral tissues (pro-atherogenic). * **HDL (High-Density Lipoprotein):** Mediates reverse cholesterol transport, removing excess cholesterol from the arterial walls (anti-atherogenic/cardioprotective). A high ratio indicates that cholesterol deposition exceeds the body's clearance capacity, making it a more sensitive indicator than individual lipid values, especially in elderly patients where metabolic profiles vary. **Why other options are incorrect:** * **Total Cholesterol:** This value includes HDL. A high total cholesterol might be driven by high HDL levels, which actually reduces risk. * **Serum LDL:** While LDL is the primary target for therapy (statin use), it does not account for the protective effect of HDL. A patient with high LDL but very high HDL may have lower risk than a patient with moderate LDL and very low HDL. * **Triglycerides:** While elevated triglycerides are an independent risk factor, they are more closely associated with metabolic syndrome and pancreatitis rather than being the primary predictor for atherosclerotic CVD. **High-Yield Clinical Pearls for NEET-PG:** * **Friedewald Formula:** LDL = Total Cholesterol – (HDL + VLDL). Note: VLDL is estimated as TG/5 (if TG <400 mg/dL). * **Apo B/Apo A-1 ratio:** Emerging as an even more accurate predictor than the LDL/HDL ratio in modern literature. * **Small dense LDL (sdLDL):** The most atherogenic subclass of LDL.

Question 437: Which of the following is an omega-6 fatty acid?

A. Alpha-Linolenic acid
B. Gamma-Linolenic acid (Correct Answer)
C. Timnodonic acid
D. Cervonic acid

Explanation: **Explanation:** Fatty acids are classified based on the position of the first double bond from the methyl ($\omega$) end. **Omega-6 ($\omega$-6) fatty acids** have their first double bond at the sixth carbon atom. **Gamma-Linolenic Acid (GLA)** is an 18-carbon polyunsaturated fatty acid (18:3; $\omega$-6) with double bonds at positions 6, 9, and 12. It is synthesized from Linoleic acid (the essential parent $\omega$-6) by the enzyme $\Delta^6$-desaturase. **Analysis of Incorrect Options:** * **Alpha-Linolenic acid (ALA):** This is an **$\omega$-3** fatty acid (18:3; $\omega$-3). It is the essential precursor for the $\omega$-3 series. * **Timnodonic acid:** Also known as **Eicosapentaenoic acid (EPA)**, it is a 20-carbon **$\omega$-3** fatty acid (20:5; $\omega$-3) found in fish oil. * **Cervonic acid:** Also known as **Docosahexaenoic acid (DHA)**, it is a 22-carbon **$\omega$-3** fatty acid (22:6; $\omega$-3) vital for retinal and brain function. **High-Yield Clinical Pearls for NEET-PG:** * **Essential Fatty Acids (EFA):** Humans lack $\Delta^{12}$ and $\Delta^{15}$ desaturases, making Linoleic acid ($\omega$-6) and Alpha-Linolenic acid ($\omega$-3) nutritionally essential. * **Arachidonic Acid:** A 20-carbon $\omega$-6 fatty acid (20:4; $\omega$-6) that serves as the precursor for pro-inflammatory prostaglandins and leukotrienes. It becomes "essential" only if Linoleic acid is deficient. * **Deficiency Sign:** EFA deficiency leads to **Phrynoderma** (toad skin), characterized by follicular hyperkeratosis on the extensor surfaces of limbs.

Question 438: Fredrickson's type II hyperlipoproteinemia is due to excess amounts of which lipoprotein?

A. VLDL remnants
B. VLDL (Correct Answer)
C. Floating LDL
D. HDL

Explanation: **Explanation:** **Fredrickson Classification** (also known as the WHO classification) categorizes hyperlipoproteinemias based on the specific lipoprotein pattern observed in the plasma. **Type IV Hyperlipoproteinemia** is characterized by an isolated elevation of **Very Low-Density Lipoproteins (VLDL)**. The underlying pathophysiology usually involves the overproduction of VLDL by the liver or a decrease in its peripheral clearance. Since VLDL is rich in endogenous triglycerides, patients typically present with significant **hypertriglyceridemia**, while cholesterol levels remain normal or only slightly elevated. **Analysis of Options:** * **VLDL (Correct):** This is the hallmark of Type IV. It is often associated with obesity, diabetes mellitus, and alcohol consumption. * **VLDL Remnants (Incorrect):** Accumulation of VLDL remnants (IDL) is the characteristic feature of **Type III** hyperlipoproteinemia (Dysbetalipoproteinemia), caused by Apo-E deficiency. * **Floating LDL (Incorrect):** This is another term for IDL (Broad-beta band), which is specific to **Type III**, not Type IV. * **HDL (Incorrect):** HDL is the "good cholesterol." High levels are generally cardioprotective and are not part of the Fredrickson classification of hyperlipoproteinemias. **High-Yield Clinical Pearls for NEET-PG:** * **Type I:** Elevated Chylomicrons (Deficiency of Lipoprotein Lipase or Apo C-II). * **Type IIa:** Elevated LDL (LDL receptor deficiency). * **Type IIb:** Elevated LDL + VLDL. * **Type III:** Elevated IDL (Apo-E deficiency; presents with palmar xanthomas). * **Type IV:** Elevated VLDL (Most common type; associated with pancreatitis risk if TGs >1000 mg/dL). * **Type V:** Elevated VLDL + Chylomicrons.

Question 439: Bile salts act as all except:

A. Emulsifying agent
B. Detergent
C. Surface tension lowering agent
D. Help in fat digestion (Correct Answer)

Explanation: **Explanation:** The question asks for the exception regarding the functions of bile salts. While bile salts are essential for the overall process of lipid absorption, they do **not** possess enzymatic activity and therefore do not directly "digest" fat. **1. Why Option D is the Correct Answer (The Exception):** Digestion is a chemical process involving the hydrolysis of bonds. This is performed by enzymes, specifically **Pancreatic Lipase**. Bile salts are biological detergents, not enzymes. Their role is purely mechanical/physical: they break down large fat globules into smaller droplets (micelles), increasing the surface area for lipase to act upon. Without lipase, bile salts alone cannot digest fat. **2. Analysis of Incorrect Options:** * **A & B (Emulsifying agent/Detergent):** Bile salts are amphipathic (containing both hydrophobic and hydrophilic regions). They surround lipid droplets, preventing them from coalescing. This detergent action creates an **emulsion**, which is vital for the subsequent action of water-soluble lipases. * **C (Surface tension lowering agent):** By acting at the oil-water interface, bile salts significantly lower the surface tension of lipid droplets. This property is the basis of the **Hay’s Test** used to detect bile salts in urine (where they cause sulfur powder to sink). **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Primary Bile Acids:** Cholic acid and Chenodeoxycholic acid (synthesized from cholesterol in the liver). * **Rate-limiting enzyme:** Cholesterol 7-alpha-hydroxylase. * **Secondary Bile Acids:** Deoxycholic acid and Lithocholic acid (formed by bacterial action in the colon). * **Enterohepatic Circulation:** 95% of bile salts are reabsorbed in the **terminal ileum**. * **Colipase:** A protein secreted by the pancreas that displaces bile salts from the fat droplet surface to allow Pancreatic Lipase to bind and begin digestion.

Question 440: All of the following are omega-3 fatty acids, EXCEPT?

A. alpha-Linolenic acid
B. Eicosapentaenoic acid
C. Docosahexaenoic acid
D. gamma-Linolenic acid (Correct Answer)

Explanation: **Explanation:** The classification of polyunsaturated fatty acids (PUFAs) into **Omega-3 (n-3)** and **Omega-6 (n-6)** depends on the position of the first double bond from the methyl (omega) end of the carbon chain. **Why gamma-Linolenic acid (GLA) is the correct answer:** **gamma-Linolenic acid (18:3; n-6)** is an **Omega-6 fatty acid**. It is synthesized in the body from Linoleic acid (the parent omega-6) by the enzyme $\Delta^6$-desaturase. Despite having three double bonds, its first double bond is at the 6th carbon from the omega end, placing it in the n-6 family. **Analysis of incorrect options (Omega-3 fatty acids):** * **alpha-Linolenic acid (ALA) (18:3; n-3):** This is the essential parent compound of the Omega-3 series. It is found primarily in plant oils (e.g., flaxseed). * **Eicosapentaenoic acid (EPA) (20:5; n-3):** A long-chain Omega-3 fatty acid found in fish oil. It serves as a precursor for Series-3 prostaglandins and Series-5 leukotrienes, which are anti-inflammatory. * **Docosahexaenoic acid (DHA) (22:6; n-3):** Another long-chain Omega-3 found in fish oil. It is vital for retinal function and brain development in infants. **High-Yield Clinical Pearls for NEET-PG:** * **Essential Fatty Acids (EFA):** Only Linoleic acid and alpha-Linolenic acid are truly essential because humans lack $\Delta^{12}$ and $\Delta^{15}$ desaturases. * **Mnemonic:** "A" comes before "G"—**A**lpha is Omega-**3**, **G**amma is Omega-**6**. * **Clinical Significance:** Omega-3 fatty acids are cardioprotective as they decrease serum triglycerides and inhibit platelet aggregation. * **Deficiency:** EFA deficiency leads to **Phrynoderma** (follicular hyperkeratosis) and poor wound healing.

Practice by Chapter

Lipid Classification and Chemistry

Practice Questions

Fatty Acid Oxidation

Practice Questions

Ketone Body Metabolism

Practice Questions

Fatty Acid Synthesis

Practice Questions

Metabolism of Triacylglycerols

Practice Questions

Phospholipid Metabolism

Practice Questions

Cholesterol Metabolism and Biosynthesis

Practice Questions

Bile Acids and Bile Salts

Practice Questions

Lipoprotein Metabolism and Transport

Practice Questions

Dyslipidemias and Atherosclerosis

Practice Questions

Prostaglandins and Eicosanoids

Practice Questions

Fatty Liver and Lipotropic Factors

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free